Categories AlphaGraphs, Earnings, Health Care
Earnings: AngioDynamics (ANGO) reports higher adj. profit for Q4; revenue up 5%
Medical device company AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported an increase in adjusted profit for the fourth quarter of 2023, aided by a 5% growth in revenues. The company also provided guidance for fiscal 2024.
Earnings, excluding special items, edged up to $0.02 per share in the May quarter from $0.01 per share in the same period of 2022. On an unadjusted basis, it was a net loss of $21.5 million or $0.54 per share, compared to a loss of $6.27 million or $0.16 per share in the prior-year quarter.
Fourth-quarter revenues increased 5% year-over-year to $91.1 million. The company expects fiscal 2024 revenues to be in the range of $328 million to $333 million.
Commenting on the results, AngioDynamics’ CEO Jim Clemmer said, “Looking ahead, we will continue to seek opportunities to further focus the portfolio in order to drive growth and margin expansion.”
Prior Performance
Most Popular
Earnings Preview: Nike (NKE) looks poised to report weak Q2 results
Nike, Inc. (NYSE: NKE) is set to report second-quarter results on Thursday, with analysts predicting a double-whammy of year-over-year decline in sales and profit. The company has been going through
FedEx (FDX) is preparing to report Q2 results. Here’s what to expect
FedEx Corporation (NYSE: FDX) has merged its operating segments into a single entity as part of an extensive reorganization aimed at cutting costs and achieving operational efficiency. The market is
What to expect when Lamb Weston (LW) reports its Q2 2025 earnings results
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) were down over 1% on Friday. The stock has gained 13% over the past three months. The frozen potato products maker is
